Related Experiment Video
Updated: Aug 19, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell
Shelby O'Connor1, Stuart Shumway, Shigeki Miyamoto
1Program in Cellular and Molecular Biology, Department of Pharmacology, University of Wisconsin-Madison, 3795 Medical Sciences Center, 1300 University Avenue, Madison, WI 53706, USA.
Abstract:
Deregulation of the transcription factor nuclear factor-kappaB (NF-kappaB) leading to its constitutive activation is frequently observed in human cancer. Because altered NF-kappaB activities often promote the survival of malignant cells, its inhibition is regarded as a promising anticancer strategy. Because activation of the latent cytoplasmic NF-kappaB complex can be induced by a wide variety of different stimuli, its deregulation may occur by an equally large number of distinct mechanisms. This diversity raises a conundrum in conceptualizing general approaches to attenuate NF-kappaB activity in cancer. Here, we provide evidence that inhibition of IkappaBalpha nuclear export is a viable target to generally abrogate constitutive NF-kappaB activity in different cancer cell types. We show that inhibition of IkappaBalpha nuclear export has an important course of events in cancer cells harboring constitutive NF-kappaB activity-an initial increase in the pool of stable nuclear NF-kappaB/IkappaBalpha complexes that leads to a reduction of constitutive NF-kappaB activity and subsequent induction of apoptosis. Importantly, similar effects on multiple different cancer cell types indicate that inhibition of nuclear export of IkappaBalpha leads to broad inhibition of constitutive NF-kappaB activation regardless of various deregulated, upstream events involved.
Insights
Targeting IkappaBalpha nuclear export offers a broad strategy to inhibit nuclear factor-kappaB (NF-kappaB) in cancer. This approach reduces constitutive NF-kappaB activity, promoting apoptosis in various cancer cell types.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Constitutive activation of nuclear factor-kappaB (NF-kappaB) is common in human cancers, promoting malignant cell survival.
- NF-kappaB deregulation can occur through diverse mechanisms, complicating general therapeutic strategies.
- Inhibiting NF-kappaB is a promising anticancer approach due to its role in cancer cell survival.
Purpose of the Study:
- To investigate the potential of inhibiting IkappaBalpha nuclear export as a general strategy to abrogate constitutive NF-kappaB activity in cancer.
- To explore the downstream effects of blocking IkappaBalpha nuclear export on cancer cell signaling and survival.
Main Methods:
- Utilized cancer cell models with constitutive NF-kappaB activity.
- Intervened with the nuclear export of IkappaBalpha.
- Assessed changes in NF-kappaB/IkappaBalpha complex localization and stability.
- Monitored NF-kappaB transcriptional activity and induction of apoptosis.
Main Results:
- Inhibition of IkappaBalpha nuclear export increased stable nuclear NF-kappaB/IkappaBalpha complexes.
- This inhibition led to a reduction in constitutive NF-kappaB activity.
- The observed effects resulted in the subsequent induction of apoptosis in cancer cells.
- These findings were consistent across multiple cancer cell types.
Conclusions:
- Inhibition of IkappaBalpha nuclear export represents a viable therapeutic target for broadly abrogating constitutive NF-kappaB activity in diverse cancers.
- This strategy effectively reduces NF-kappaB signaling and induces apoptosis, irrespective of upstream deregulated events.
- Targeting IkappaBalpha nuclear export offers a unified approach to combatting various cancers driven by NF-kappaB.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
